Dr. Daniel Johnson, MD
Claim this profileOchsner Clinic Foundation
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
25 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
2Non-Small Cell Lung Cancer
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Daniel Johnson, MD is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting1 award Phase 2
More about Daniel Johnson, MD
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniel Johnson, MD has experience with
- Nivolumab
- Docetaxel
- Carboplatin
- Placebo
- Pantoprazole
- Placebo (0.9% Saline)
Breakdown of trials Daniel Johnson, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Johnson, MD specialize in?
Daniel Johnson, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Daniel Johnson, MD currently recruiting for clinical trials?
Yes, Daniel Johnson, MD is currently recruiting for 2 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Daniel Johnson, MD has studied deeply?
Yes, Daniel Johnson, MD has studied treatments such as Nivolumab, Docetaxel, Carboplatin.
What is the best way to schedule an appointment with Daniel Johnson, MD?
Apply for one of the trials that Daniel Johnson, MD is conducting.
What is the office address of Daniel Johnson, MD?
The office of Daniel Johnson, MD is located at: Ochsner Clinic Foundation, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Clinic Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.